Acera Surgical

Acera Surgical Inc. ("Acera," St. Louis, Missouri) is a bioscience company commercializing a portfolio of implantable nanomedical scaffolds for regenerative medical applications. Acera's products exhibit a structure similar to native extracellular matrix (ECM) and support effective healing. Acera is currently commercializing its first two products, the Cerafix® Dural Substitute and the Restrata® Wound Matrix, both FDA cleared via 510(k).